Pila Pharma Q1’22: New project revealed
Research Note
2022-04-26
14:32
Redeye leaves its comment on Pila Pharma following the announcement of its Q1 report. Highlights include revealing a new pipeline candidate and certification of API. The financials were broadly in line with expectations.
FE
Filip Einarsson
Disclosures and disclaimers